Filing Details
- Accession Number:
- 0000886163-18-000121
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-08-17 19:37:44
- Reporting Period:
- 2018-08-16
- Accepted Time:
- 2018-08-17 19:37:44
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 886163 | Ligand Pharmaceuticals Inc | LGND | Pharmaceutical Preparations (2834) | 770160744 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1208906 | L John Higgins | 3911 Sorrento Valley Boulevard, Ste 110 San Diego CA 92121 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2018-08-16 | 3,007 | $14.47 | 110,426 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-16 | 21,507 | $241.33 | 88,919 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2018-08-17 | 12,993 | $14.47 | 101,912 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2018-08-17 | 12,993 | $243.00 | 88,919 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2018-08-16 | 3,007 | $0.00 | 3,007 | $14.47 |
| Common Stock | Non-Qualified Stock Option (right to buy) | Disposition | 2018-08-17 | 12,993 | $0.00 | 12,993 | $14.47 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 171,993 | 2022-02-09 | No | 4 | M | Direct | |
| 159,000 | 2022-02-09 | No | 4 | M | Direct |
Footnotes
- The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on June 22, 2018, in accordance with Rule 10b5-1.
- Grant to reporting person of options, exercisable over a 4-year period measured from the date of grant, 12-1/2% after six months, then 1/48th of the Option Shares per month thereafter. The date of grant is 02/09/12.
Billionaire Hedge Funds
